The administration of ASP improved iron availability, abrogated the suppression of erythropoiesis by inflammatory cytokines, and effectively reversed anemia via inhibiting inflammatory hepcidin and NF-κB activation in ACD rats (Figure 7). The gene discussed is HAMP; the disease is anemia (phenotype).